Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R, et al.

N Engl J Med. 1995 Sep 28;333(13):832-8.

2.

The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.

Karpati G, Acsadi G.

Muscle Nerve. 1993 Nov;16(11):1141-53. Review.

PMID:
8413366
3.
4.

Myoblast transfer and gene therapy in muscular dystrophies.

Pagel CN, Morgan JE.

Microsc Res Tech. 1995 Apr 15;30(6):469-79. Review.

PMID:
7599358
5.

Immunobiology and the future of myoblast transfer therapy.

Smythe GM, Hodgetts SI, Grounds MD.

Mol Ther. 2000 Apr;1(4):304-13. Review.

6.

Gene therapy in Duchenne muscular dystrophy.

Inui K, Okada S, Dickson G.

Brain Dev. 1996 Sep-Oct;18(5):357-61. Review.

PMID:
8891229
7.

Muscle-derived stem cells: potential for muscle regeneration.

Huard J, Cao B, Qu-Petersen Z.

Birth Defects Res C Embryo Today. 2003 Aug;69(3):230-7. Review.

PMID:
14671776
8.

Duchenne's muscular dystrophy: review and recent scientific findings.

Evans BK, Goyne C.

Am J Med Sci. 1991 Aug;302(2):118-23. Review.

PMID:
1897557
9.

Myoblast transfer therapy: is there any light at the end of the tunnel?

Mouly V, Aamiri A, Périé S, Mamchaoui K, Barani A, Bigot A, Bouazza B, François V, Furling D, Jacquemin V, Negroni E, Riederer I, Vignaud A, St Guily JL, Butler-Browne GS.

Acta Myol. 2005 Oct;24(2):128-33. Review.

PMID:
16550930
10.

Gene therapy for muscle diseases.

Coovert DD, Burghes AH.

Curr Opin Neurol. 1994 Oct;7(5):463-70. Review.

PMID:
7804468
11.

Leber's congenital amaurosis with Duchenne's muscular dystrophy.

Hazariwala K, Brownstein S, Polomeno R, Little JM, Labuda D.

Can J Ophthalmol. 1990 Jun;25(4):202-7. Review.

PMID:
1972344
12.

Myoblast transplantation: a possible surgical treatment for a severe pediatric disease.

Palmieri B, Tremblay JP.

Surg Today. 2010 Oct;40(10):902-8. doi: 10.1007/s00595-009-4242-z. Epub 2010 Sep 25. Review.

PMID:
20872191
13.

Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.

Wallace GQ, McNally EM.

Annu Rev Physiol. 2009;71:37-57. doi: 10.1146/annurev.physiol.010908.163216. Review.

PMID:
18808326
14.

Past, present and future of myoblast transplantation in the treatment of Duchenne muscular dystrophy.

Palmieri B, Tremblay JP, Daniele L.

Pediatr Transplant. 2010 Nov;14(7):813-9. doi: 10.1111/j.1399-3046.2010.01377.x. Review.

PMID:
20963914
15.

Molecular targets to treat muscular dystrophies.

Kinter J, Sinnreich M.

Swiss Med Wkly. 2014 Feb 19;144:w13916. doi: 10.4414/smw.2014.13916. Review.

16.

Recent progress in satellite cell/myoblast engraftment -- relevance for therapy.

Briggs D, Morgan JE.

FEBS J. 2013 Sep;280(17):4281-93. doi: 10.1111/febs.12273. Epub 2013 Apr 24. Review.

17.

Experimental and therapeutic approaches to muscular dystrophies.

Skuk D, Vilquin JT, Tremblay JP.

Curr Opin Neurol. 2002 Oct;15(5):563-9. Review.

PMID:
12352000
18.

[Lessons of dystrophin].

Desnuelle C.

Presse Med. 1994 May 21;23(19):896-900. Review. French.

PMID:
7937619
19.

The physiological evaluation of gene therapies of dystrophin-deficient muscles.

Gillis JM, Deconinck N.

Adv Exp Med Biol. 1998;453:411-6; discussion 417. Review. No abstract available.

PMID:
9889852
20.

[Molecular therapy for muscular dystrophy].

Shimizu Y, Takeda S.

Nihon Rinsho. 2010 Aug;68 Suppl 8:650-3. Review. Japanese. No abstract available.

PMID:
20976941

Supplemental Content

Support Center